The HCPLive nephrology page is a resource for medical news and expert insights on kidney disease. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments in nephrology, and more.
May 8th 2024
Findings suggest the potential prognostic value of time-averaged serum uric acid for predicting disease progression in IgAN.
Expert Illustrations & Commentaries™: Exploring the Role of Novel Agents for the Management of IgA Nephropathy
View More
‘REEL’ Time Patient Counseling™: Navigating the Complex Journey of Diagnosing and Managing Fabry Disease
View More
Patient, Provider & Caregiver Connection™: Implementing an Effective Management Plan to Improve Outcomes in IgA Nephropathy
View More
Bioengineered Blood Vessel Offers Potential Improvements for Dialysis Patients
November 21st 2013Initial results from human clinical trials involving the use of bioengineered blood vessels could point the way to cost-effective alternative therapies for hemodialysis patients with end-stage renal disease.
Vascular Calcification Shown on X-Ray Assesses Cardiovascular Risks in Chronic Kidney Disease
November 8th 2013A recent study presented at Kidney Week 2013 suggests that a plain X-ray is a reliable and inexpensive tool for assessing the risks of cardiovascular events and death in patients who have chronic kidney disease (CKD) and are not on dialysis.
Study Shows Tolvaptan is Effective in Treating Autosomal Dominant Polycystic Kidney Disease
November 4th 2012Results from the TEMPO trial presented at Kidney Week 2012 show that treatment with tolvaptan slowed the increase in total kidney volume and the decline in kidney function in patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD).
Reducing the Risk of Rejection Following Kidney Transplant in Patients with End-stage Renal Disease
November 2nd 2012The powerful immunosuppressive drugs used to prevent allograft rejection are associated with severe side effects. A "mixed chimerism" strategy in which patients undergo simultaneous bone marrow and kidney transplant from the same donor may improve transplant survival and reduce the need for these drugs.
Why is Peritoneal Dialysis Underutilized in the US Compared to Hemodialysis?
November 2nd 2012Use of peritoneal dialysis in patients with end-stage renal disease is declining due to lack of physician training and awareness, financial disincentives, and other factors. However, with proper patient and provider education, it is possible to grow a successful peritoneal dialysis program.